Managing capivasertib-induced hyperglycemia: a report of 3 cases. [PDF]
Cuan K, Oh SY, Milosavljevic J, Wong BY.
europepmc +1 more source
Dapagliflozin & pioglitazone combination therapy in T2DM with or without MASLD - a systematic review and meta-analysis: PRO-2 study. [PDF]
Joshi S +17 more
europepmc +1 more source
Comparative effectiveness of pioglitazone and sitagliptin added to metformin and sulfonylurea in patients with type 2 diabetes: An emulated target trial. [PDF]
Kim TH +14 more
europepmc +1 more source
Design and <i>in silico</i> evaluation of Thiazole-Isoxazole hybrids as PPARγ-Targeted antidiabetic agents. [PDF]
Pv A +7 more
europepmc +1 more source
Exploring Disulfide Bridge as a Tool to Improve Pioglitazone's Neuroprotective Potential: Toward the Development of Prolonged-Acting MAO-B/PPARγ Modulators. [PDF]
Basagni F +12 more
europepmc +1 more source
Efficacy of pioglitazone in correcting ovulatory functions among polycystic ovary syndrome patients. [PDF]
Khalid U +5 more
europepmc +1 more source
Bioequivalence of Fixed-Dose Dapagliflozin-Pioglitazone in Healthy Indian Adults: Results From the Randomized Crossover PRO-4 Study. [PDF]
Prasath JH +8 more
europepmc +1 more source
Pioglitazone for the treatment of alcohol use disorder: A randomized controlled trial. [PDF]
Dieperink E +5 more
europepmc +1 more source
Metabolic Dysfunction-Associated Steatotic Liver Disease: Current Treatment Strategies and Novel Therapies. [PDF]
Shenoy A, Ahmed A, Kim D.
europepmc +1 more source
The new era of MASH pharmacotherapy: a comprehensive review of FDA-approved and emerging agents. [PDF]
Qasim A, Alataa R, Veena F, Shehi E.
europepmc +1 more source

